Clinical Trials Directory

Trials / Unknown

UnknownNCT02231983

Clinical Characteristics and Genetic Profiles of Severe Combined Immunodeficiency in China

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Shanghai Children's Medical Center · Academic / Other
Sex
All
Age
2 Months – 2 Years
Healthy volunteers
Not accepted

Summary

Severe combined immunodeficiency (SCID), a rare primary immunodeficiency dieases (PID), is poorly characterized in mainland China. We meant to explore the patients with SCID refered to our hospital and summarize their clinical manifestations and genetic features.

Detailed description

Diagnostic criteria were based on recommendations by the Pan-American Group for Immunodeficiency and the European Society for Immunodeficiencies, which included failure to thrive, persistent diarrhea, respiratory symptoms, and oral candidiasis, or Pneumocystis pneumonia, severe bacterial infections, and disseminated Bacillus Calmette-Guérin (BCG) infection during the first 2 to 7 months of life. In addition, patients included in the study were \<2 years of age, with either transplacentally acquired maternal T cells or \<20 % CD3+ T cells, the absolute lymphocyte count (ALC) \<3000/mm3. Exclusion criteria include HIV infection, congenital rubella, DiGeorge syndrome, Zap70 deficiency, Cartilage hair hypoplasia, PNP deficiency and MHC class II deficiency.

Conditions

Interventions

TypeNameDescription
GENETICgene sequencingAmplify and identify exons from gene IL-2RG by PCR and agarose gel electrophoresis, and then followed by gene sequencing.

Timeline

Start date
2014-09-01
Primary completion
2016-09-01
Completion
2016-09-01
First posted
2014-09-04
Last updated
2014-09-04

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02231983. Inclusion in this directory is not an endorsement.